Bertrand Cottineau

R&D Group Head Axplora

Seminars

Tuesday 24th February 2026
Evaluating Efficient Bioburden Control From Drug-Linker to ADC Drug Substance
11:30 am
  • Navigating a holistic and risk-based approach for both drug-linker and ADC drug substance process
  • Exploring a case study of environmental monitoring of drug linker and ADC drug substance facilities
  • Using case study examples to assess drug-linker and ADC microbial methods
Bertrand Cottineau Speaker Photo - 16th World ADC London Summit